Explore

Trendline Trendline
Hiteck Pharmaceutical and LexBio Present New Findings on HT016 for Immune Disorders

Hiteck Pharmaceutical and LexBio Present New Findings on HT016 for Immune Disorders

Hiteck Pharmaceutical and LexBio Present New Findings on HT016 for Immune Disorders
Trendline Trendline
EnPlusOne Biosciences Unveils Advancements in RNA Synthesis at Boston Conferences

EnPlusOne Biosciences Unveils Advancements in RNA Synthesis at Boston Conferences

EnPlusOne Biosciences Unveils Advancements in RNA Synthesis at Boston Conferences
Trendline Trendline
Forge Biologics to Present Gene Therapy Advancements at ASGCT Annual Meeting

Forge Biologics to Present Gene Therapy Advancements at ASGCT Annual Meeting

Forge Biologics to Present Gene Therapy Advancements at ASGCT Annual Meeting
Trendline Trendline
JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston

JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston

JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston
Trendline Trendline
Ankyra Therapeutics Presents Anchored Immunotherapy at PEGS Boston 2026

Ankyra Therapeutics Presents Anchored Immunotherapy at PEGS Boston 2026

Ankyra Therapeutics Presents Anchored Immunotherapy at PEGS Boston 2026
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development
Trendline Trendline
Benchling Biologics Launches No-Code Antibody Design Platform to Streamline R Processes

Benchling Biologics Launches No-Code Antibody Design Platform to Streamline R Processes

Benchling Biologics Launches No-Code Antibody Design Platform to Streamline R Processes
Trendline Trendline
Ankyra Therapeutics Showcases Anchored Immunotherapy at PEGS Boston 2026

Ankyra Therapeutics Showcases Anchored Immunotherapy at PEGS Boston 2026

Ankyra Therapeutics Showcases Anchored Immunotherapy at PEGS Boston 2026
Trendline Trendline
Ankyra Therapeutics Presents Preclinical Data on Anchored Immunotherapy at PEGS Boston 2026

Ankyra Therapeutics Presents Preclinical Data on Anchored Immunotherapy at PEGS Boston 2026

Ankyra Therapeutics Presents Preclinical Data on Anchored Immunotherapy at PEGS Boston 2026
Trendline Trendline
4basebio Unveils Enzymatic ssDNA Platform to Enhance Gene Editing

4basebio Unveils Enzymatic ssDNA Platform to Enhance Gene Editing

4basebio Unveils Enzymatic ssDNA Platform to Enhance Gene Editing
AP News AP News
Small study hints that revving up immune cells might help fight HIV

Small study hints that revving up immune cells might help fight HIV

Scientists are supercharging patients' own immune cells to try to fight HIV without today's drugs
Trendline Trendline
EnPlusOne Biosciences Advances RNA Therapeutics with New Enzymatic Synthesis Platform

EnPlusOne Biosciences Advances RNA Therapeutics with New Enzymatic Synthesis Platform

EnPlusOne Biosciences Advances RNA Therapeutics with New Enzymatic Synthesis Platform